摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Dodecyl-6-(3-hydroxy-propyl)-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester | 150252-65-6

中文名称
——
中文别名
——
英文名称
4-Dodecyl-6-(3-hydroxy-propyl)-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester
英文别名
——
4-Dodecyl-6-(3-hydroxy-propyl)-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester化学式
CAS
150252-65-6
化学式
C21H38N2O4
mdl
——
分子量
382.544
InChiKey
SDMOTTUWMNMWQQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    503.6±50.0 °C(predicted)
  • 密度:
    1.017±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.18
  • 重原子数:
    27.0
  • 可旋转键数:
    15.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    87.66
  • 氢给体数:
    3.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    4-Dodecyl-6-(3-hydroxy-propyl)-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid methyl ester盐酸 作用下, 以 甲醇 为溶剂, 生成 (5S,9S,10R)-9-Dodecyl-7-oxo-1-oxa-6,8-diaza-spiro[4.5]decane-10-carboxylic acid methyl ester 、 (5S,9R,10R)-9-Dodecyl-7-oxo-1-oxa-6,8-diaza-spiro[4.5]decane-10-carboxylic acid methyl ester 、 (5R,9R,10R)-9-Dodecyl-7-oxo-1-oxa-6,8-diaza-spiro[4.5]decane-10-carboxylic acid methyl ester 、 (5R,9S,10R)-9-Dodecyl-7-oxo-1-oxa-6,8-diaza-spiro[4.5]decane-10-carboxylic acid methyl ester
    参考文献:
    名称:
    Biomimetic synthesis of (.+-.)-crambines A, B, C1, and C2. Revision of the structure of crambines B and C1
    摘要:
    Crambines A (7) (eight steps, 22%), B (45d) (eight Steps, 19%), C1 (9d) (seven steps, 21%), and C2 (9a) (seven steps, 27%) have been synthesized expediently and stereospecifically by a biomimetic route from methyl acetoacetate. Aminodihydropyrimidines 39 and 40 are formed efficiently from enone ester 36 by a two-step procedure involving addition of O-methylisourea to give methoxydihydropyrimidine 37 followed by displacement of the methoxy group of 37 with ammonia. Hydrogenolysis of 40a and 40d afford crambines C2 and C1, respectively. Mesylation of the alcohol of 39a or 40a followed by Et3N-catalyzed cyclization and hydrogenolysis affords crambine A (7). Aminal formation from 39d or 40d in CHCl3 followed by hydrogenolysis proceeds stereospecifically to provide crambine B (45d). The structure of crambine B has been revised to the stereochemistry shown in 45 and both crambines B and Cl have a seven rather than five-carbon guanidino alkyl chain.
    DOI:
    10.1021/jo00067a014
  • 作为产物:
    参考文献:
    名称:
    Biomimetic synthesis of (.+-.)-crambines A, B, C1, and C2. Revision of the structure of crambines B and C1
    摘要:
    Crambines A (7) (eight steps, 22%), B (45d) (eight Steps, 19%), C1 (9d) (seven steps, 21%), and C2 (9a) (seven steps, 27%) have been synthesized expediently and stereospecifically by a biomimetic route from methyl acetoacetate. Aminodihydropyrimidines 39 and 40 are formed efficiently from enone ester 36 by a two-step procedure involving addition of O-methylisourea to give methoxydihydropyrimidine 37 followed by displacement of the methoxy group of 37 with ammonia. Hydrogenolysis of 40a and 40d afford crambines C2 and C1, respectively. Mesylation of the alcohol of 39a or 40a followed by Et3N-catalyzed cyclization and hydrogenolysis affords crambine A (7). Aminal formation from 39d or 40d in CHCl3 followed by hydrogenolysis proceeds stereospecifically to provide crambine B (45d). The structure of crambine B has been revised to the stereochemistry shown in 45 and both crambines B and Cl have a seven rather than five-carbon guanidino alkyl chain.
    DOI:
    10.1021/jo00067a014
点击查看最新优质反应信息

文献信息

  • Biomimetic synthesis of the bicyclic guanidine moieties of crambines A and B
    作者:Barry B. Snider、Zhongping Shi
    DOI:10.1021/jo00035a005
    日期:1992.4
    The acyl portions of crambine A (six steps, 29% overall yield) and crambine B (six steps, 26% overall yield) have been efficiently and stereospecifically synthesized from methyl acetoacetate.
查看更多